Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 9, 2009 - Issue 2
Submit an article Journal homepage
1,339
Views
15
CrossRef citations to date
0
Altmetric
Review

Applying Programme Budgeting Marginal Analysis in the health sector: 12 years of experience

Rachel Grocott Health Economist/Team Leader, Assessment, PHARMAC, PO Box 10–254, Wellington 6011, New Zealand. [email protected]
Pages 181-187 | Published online: 09 Jan 2014

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Frank G. Sandmann, Sarah Mostardt, Stefan K. Lhachimi & Andreas Gerber-Grote. (2018) The efficiency-frontier approach for health economic evaluation versus cost-effectiveness thresholds and internal reference pricing: combining the best of both worlds?. Expert Review of Pharmacoeconomics & Outcomes Research 18:5, pages 475-486.
Read now
Stuart J Peacock, Craig Mitton, Danny Ruta, Cam Donaldson, Angela Bate & Lindsay Hedden. (2010) Priority setting in healthcare: towards guidelines for the program budgeting and marginal analysis framework. Expert Review of Pharmacoeconomics & Outcomes Research 10:5, pages 539-552.
Read now

Articles from other publishers (13)

Ben Main, Marcell Csanadi & Piotr Ozieranski. (2022) Pricing strategies, executive committee power and negotiation leverage in New Zealand's containment of public spending on pharmaceuticals. Health Economics, Policy and Law 17:3, pages 348-365.
Crossref
María Eugenia Esandi, Iñaki Gutiérrez-Ibarluzea, Nora Ibargoyen-Roteta & Brian Godman. (2019) An evidence-based framework for identifying technologies of no or low-added value (NLVT). International Journal of Technology Assessment in Health Care 36:1, pages 50-57.
Crossref
Letlhogonolo Makhele, Moliehi Matlala, Mncengeli Sibanda, Antony P. Martin & Brian Godman. (2019) A Cost Analysis of Haemodialysis and Peritoneal Dialysis for the Management of End-Stage Renal Failure At an Academic Hospital in Pretoria, South Africa. PharmacoEconomics - Open 3:4, pages 631-641.
Crossref
Syed Shahzad Hasan, Chia Siang Kow, Dalia Dawoud, Omneya Mohamed, Darrin Baines & Zaheer-Ud-Din Babar. (2019) Pharmaceutical Policy Reforms to Regulate Drug Prices in the Asia Pacific Region: The Case of Australia, China, India, Malaysia, New Zealand, and South Korea. Value in Health Regional Issues 18, pages 18-23.
Crossref
Wanrudee Isaranuwatchai, Ahmed M. Bayoumi, Emilie Renahy, Rebecca Cheff & Patricia O’Campo. (2018) Using decision methods to examine the potential impact of intersectoral action programs. BMC Research Notes 11:1.
Crossref
Ian Cromwell, Stuart J Peacock & Craig Mitton. (2015) ‘Real-world’ health care priority setting using explicit decision criteria: a systematic review of the literature. BMC Health Services Research 15:1.
Crossref
Bonny Parkinson, Catherine Sermet, Fiona Clement, Steffan Crausaz, Brian Godman, Sarah Garner, Moni Choudhury, Sallie-Anne Pearson, Rosalie Viney, Ruth Lopert & Adam G. Elshaug. (2015) Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review. PharmacoEconomics 33:9, pages 905-924.
Crossref
Scott Metcalfe, Rachel Grocott & Dilky Rasiah. (2014) Comment on “Ahead of Its Time? Reflecting on New Zealand’s Pharmac Following its 20th Anniversary”. PharmacoEconomics 32:10, pages 1031-1033.
Crossref
Robin Gauld. (2014) Ahead of Its Time? Reflecting on New Zealand’s Pharmac Following Its 20th Anniversary. PharmacoEconomics 32:10, pages 937-942.
Crossref
Michael Wonder & Richard Milne. (2014) Is there any evidence that the Trans Pacific Partnership Agreement will threaten access to affordable medicines and health equity in New Zealand?. Health Policy 116:2-3, pages 234-235.
Crossref
Zaheer-Ud-Din Babar & Susan Francis. (2014) Identifying priority medicines policy issues for New Zealand: a general inductive study. BMJ Open 4:5, pages e004415.
Crossref
Duncan Mortimer. (2010) Reorienting programme budgeting and marginal analysis (PBMA) towards disinvestment. BMC Health Services Research 10:1.
Crossref
Scott Metcalfe & Rachel Grocott. (2010) Comments on “Simoens, S. Health Economic Assessment: A Methodological Primer. Int. J. Environ. Res. Public Health 2009, 6, 2950-2966”—New Zealand in Fact Has No Cost-Effectiveness Threshold. International Journal of Environmental Research and Public Health 7:4, pages 1831-1834.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.